INDIANAPOLIS, Oct. 19, 2016 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has granted approval of LARTRUVO™ (olaratumab injection, 10 mg/mL), in combination with doxorubicin, for the treatment of adults with soft tissue sarcoma (STS) with a histologic subtype for which …
Tag Archives: sarcoma
October, 2016
December, 2015
-
7 December
Merck Drops Development of Cancer Drug After Studies Fail
Darmstadt, Germany, December 7, 2015 – Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that it is not planning to file for approval of evofosfamide in advanced soft tissue sarcoma and advanced pancreatic adenocarcinoma. The decision was made in light of results from two Phase III …